Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

T-cell responses against chronic lymphocytic leukemia cells: Implications for immunotherapy

  • Angela M. Krackhardt
  • , Sabine Harig
  • , Mathias Witzens
  • , Ryan Broderick
  • , Patrick Barrett
  • , John G. Gribben
  • Harvard Medical School
  • Dana Farber Cancer Institute

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

80 Zitate (Scopus)

Abstract

Chronic lymphocytic leukemia (CLL) cells are ineffective antigen-presenting cells (APCs) although CD401-activated CLL cells can stimulate proliferation of autologous and allogeneic T cells. We examined the antigen-presenting capacity of CD40-activated CLL cells as well as dendritic cells pulsed with apoptotic bodies of CLL cells to generate autologous and allogeneic immune responses against CLL cells. Both APC types were capable of generating T-cell lines that proliferate specifically in response to unstimulated CLL cells. Whereas cytotoxic responses against stimulated and unstimulated CLL cells could be repeatedly generated by allogeneic healthy donors, autologous cytotoxic immune responses against CD40-activated and native CLL cells were rarely detected. However, T cells isolated from patients with CLL could recognize and lyse allogeneic stimulated and unstimulated CLL cells, demonstrating that cytotoxic T cells from these tumor-bearing patients are functionally intact.

OriginalspracheEnglisch
Seiten (von - bis)167-173
Seitenumfang7
FachzeitschriftBlood
Jahrgang100
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 1 Juli 2002
Extern publiziertJa

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gute Gesundheit und Wohlergehen
    SDG 3 – Gute Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „T-cell responses against chronic lymphocytic leukemia cells: Implications for immunotherapy“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren